Evidence map›Paper›PMID 34421862›Full record

ArticleFrontiers in microbiology2021

Conservation of S20 as an Ineffective and Disposable IFNγ-Inducing Determinant of

Calvin Hon, Johannes Friesen, Alyssa Ingmundson, Diana Scheppan, Julius C R Hafalla, Katja Müller, Kai Matuschewski

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Calvin HonDepartment of Molecular Parasitology, Institute of Biology, Humboldt University, Berlin, Germany.
Johannes FriesenParasitology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
Alyssa IngmundsonDepartment of Molecular Parasitology, Institute of Biology, Humboldt University, Berlin, Germany.
Diana ScheppanParasitology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
Julius C R HafallaDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Katja MüllerDepartment of Molecular Parasitology, Institute of Biology, Humboldt University, Berlin, Germany.
Kai MatuschewskiDepartment of Molecular Parasitology, Institute of Biology, Humboldt University, Berlin, Germany.
Humboldt-Universität zu Berlin · DEMax Planck Institute for Infection Biology · DELondon School of Hygiene & Tropical Medicine · GB

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/L000601/1
6 · The paper itself

Abstract

Despite many decades of research to develop a malaria vaccine, only one vaccine candidate has been explored in pivotal phase III clinical trials. This candidate subunit vaccine consists of a portion of a single

Indexed as

antigenCD8+ T cellsimmunizationmalariaPlasmodiumpre-erythrocytic stagesporozoitewhole organism vaccine

Identifiers

PMID34421862
PMCPMC8377727
OpenAlexW3187534930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.